Want to join the conversation?
$JCP 2Q15 PR: JCP improved its SG&A and EBITDA guidance and reiterated its remaining FY15 guidance as follows: Comparable store sales expected to increase 4-5%; GM expected to improve 100-150 BPs; SG&A expected to decrease $120MM; EBITDA approx. $620MM; CapEx to be in range of $250-300MM; and free cash flow expected to be breakeven.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?